Variable | Model 1 (forced entry) | Model 2 (backward elimination*) | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Patients who received corticosteroid | 0.370 | 0.168–0.817 | 0.014 | 0.378 | 0.173–0.827 | 0.015 |
Number of concomitant immunosuppressant medications | ||||||
0 | Reference | Â | Â | Â | Â | Â |
1 | 2.815 | 1.161–6.824 | 0.022 | 2.724 | 1.131–6.561 | 0.025 |
2 | 3.559 | 1.252–10.112 | 0.017 | 3.335 | 1.187–9.374 | 0.022 |
≥ 3 | 12.879 | 3.303–50.225 | < 0.001 | 11.764 | 3.091–44.77 | < 0.001 |
Paediatric/adolescent patients (≤18 years) | 2.601 | 1.034–6.542 | 0.042 | 2.075 | 0.926–4.648 | 0.076 |
Elderly patients (≥65 years) | 1.307 | 0.611–2.796 | 0.490 |  |  |  |
Patients who received GMA retreatment | 1.120 | 0.518–2.421 | 0.774 |  |  |  |
Patients with anaemia (haemoglobin < 10 g/dL) | 2.124 | 1.088–4.146 | 0.027 | 2.019 | 1.054–3.867 | 0.034 |
Sex (female) | 1.595 | 0.835–3.045 | 0.157 | 1.582 | 0.838–2.984 | 0.157 |
Type of IBD (UC) | 0.506 | 0.196–1.308 | 0.160 | 0.519 | 0.204–1.322 | 0.169 |
Duration of disease (year) | 1.015 | 0.978–1.054 | 0.434 |  |  |  |